BBIO
BridgeBio Pharma Inc
Price:  
54.26 
USD
Volume:  
1,492,722.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BridgeBio EV/EBITDA

-187.6%
Upside

As of 2025-10-26, the EV/EBITDA ratio of BridgeBio Pharma Inc (BBIO) is -16.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BridgeBio's latest enterprise value is 10,372.88 mil USD. BridgeBio's TTM EBITDA according to its financial statements is -622.03 mil USD. Dividing these 2 quantities gives us the above BridgeBio EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.1x - 13.7x 13.4x
Forward P/E multiples 14.1x - 16.9x 15.8x
Fair Price (45.88) - (44.71) (47.51)
Upside -184.6% - -182.4% -187.6%
54.26 USD
Stock Price
(47.51) USD
Fair Price

BridgeBio EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA